Dear Secretary Lutnick and Members of the Bureau of Industry and Security:

As members of the Heart Valve Disease Policy Task Force, a national group of 30 leaders including
clinician and patient advocates, we appreciate the opportunity to comment on the Department’s
investigation into the national security implications of medical product imports under Section 232 of the
Trade Expansion Act of 1962.

 

Read full comment letter here.